You are here: Industry Insights > Cancer

News List

Cancer CART therapy: What are the benefits and stakes? expresspharma
June 15, 2020
Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how R&D, regulatory and commercial activities have globally bolstered the technological promise of Cancer CART therapy and ...
NHS waiting lists could hit 10m by year end pharmatimes
June 11, 2020
NHS waiting lists could swell to 10 million by the end of the year, and possibly higher if there is a second wave of COVID-19 and a lack of treatment or a vaccine, the NHS Confederation warns.
Scientists identify targets for COVID-19 vaccine using cancer immunotherapy tools worldpharmanews
June 10, 2020
Cancer researchers at Children's Hospital of Philadelphia (CHOP) have harnessed tools used for the development of cancer immunotherapies and adapted them to identify regions of the SARS-CoV-2 virus to target with a vaccine...
AstraZeneca teams up with Accent Therapeutics for cancer therapies pharmaceutical-technology
June 05, 2020
The partners aim for therapeutics that act on RNA-modifying proteins (RMPs) to treat cancer.
Coronavirus bottleneck leaves 2m waiting for cancer care pharmatimes
June 04, 2020
Around 2.4 million people in the UK are currently waiting for cancer screening, tests or cancer treatment, a new analysis by Cancer Research UK has found.
UK study highlights potential of genetic screening for prostate cancer pharmatimes
June 02, 2020
Findings of pioneering study unveiled at ASCO 2020 show that genetic screening for prostate cancer in GP surgeries could be effective at picking up otherwise undiagnosed cases of the disease in seemingly healthy males.
Gilead and Arcus Ink $2B Cancer Partnership contractpharma
June 01, 2020
To co-develop and co-commercialize next-generation cancer immunotherapies.
Researchers develop AI tool able to predict cancer relapse pharmatimes
May 29, 2020
A team of computer scientists and pathologists have trained an artificial intelligence (AI) tool to identify lung cancer patients who have a higher risk of disease recurrence following treatment.
Gilead and Arcus Biosciences partner to develop cancer drugs pharmaceutical-technology
May 29, 2020
Gilead Sciences has partnered with Arcus Biosciences to jointly develop and commercialise current and future cancer therapeutic candidates in the latter’s pipeline.
NICE issues final guidance on NHS use of Bayer's Vitrakvi pharmatimes
May 28, 2020
The National Institute for Health and Care Excellence (NICE) has published final guidance recommending NHS use of Bayer's Vitrakvi (larotrectinib) for a variety of cancers.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page